Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa

The ability of combinations of azlocillin and tobramycin to prevent or delay resistance development in eight Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients was studied using chequerboard titration and in-vitro serial subculture. No isolate had developed resistance to tobramycin a...

Full description

Bibliographic Details

Published in:	Journal of antimicrobial chemotherapy Vol. 44; no. 3; p. 389
Main Authors:	Wu, Y L, Scott, E M, Po, A L, Tariq, V N
Format:	Journal Article
Language:	English
Published:	England 01.09.1999
Subjects:	Anti-Bacterial Agents - pharmacology Azlocillin - pharmacology Cystic Fibrosis - microbiology Drug Resistance, Microbial - physiology Drug Therapy, Combination - pharmacology Humans Microbial Sensitivity Tests Penicillins - pharmacology Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - physiology Pseudomonas Infections - microbiology Tobramycin - pharmacology
ISSN:	0305-7453
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!